Mitral Valve Replacement in Infants and Children: Five-Year Outcomes of the HALO Clinical Trial

Fawwaz R Shaw1, Brian Kogon2, Jonathan Chen3

  • 1Department of Cardiothoracic Surgery, Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia.

PubMed

Insights

Mitral valve replacement in infants using the 15-mm St Jude mechanical valve showed acceptable hemodynamics but carried significant risks. Avoid low-molecular-weight heparin for anticoagulation in pediatric patients, as valve replacement is often necessary.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Biomedical Engineering

Background:

  • Mitral valve disease in children often necessitates surgical intervention.
  • While repair is preferred, mitral valve replacement (MVR) is sometimes required for pediatric patients.
  • This study evaluates the 15-mm St Jude mechanical mitral valve in a pediatric population.

Purpose of the Study:

  • To assess the safety and efficacy of the 15-mm St Jude mechanical mitral valve in pediatric patients undergoing MVR.
  • To report outcomes including mortality, complications, and reinterventions in this cohort.
  • To provide insights into anticoagulation strategies for pediatric MVR patients.

Main Methods:

  • A multi-institutional Investigational Device Exemption trial.
  • 23 children (mean age 7.8 months) received the 15-mm St Jude mechanical mitral valve.
  • 100% complete follow-up was achieved for all patients.

Main Results:

  • The 15-mm St Jude mechanical mitral valve demonstrated satisfactory hemodynamics in small children.
  • The 1- and 5-year freedom from death or valve explantation was 71.0%.
  • Complications included 6 deaths (all within 12 months, none valve-related), 4 pacemaker insertions, 3 thromboses requiring explantation, and 5 bleeding events.

Conclusions:

  • The 15-mm St Jude mechanical mitral valve offers satisfactory hemodynamics for pediatric MVR.
  • Mortality and complication rates in this high-risk pediatric group are significant.
  • Low-molecular-weight heparin should be avoided as primary anticoagulation; eventual valve replacement is likely.
Abstract

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...